Feb 22, 2022 by Kody KesterWhy I'll Be Owning Realty Income Well Into RetirementWhat Realty Income lacks in terms of excitement, it makes up for with its remarkable consistency.
Feb 21, 2022 by Kody KesterIs Now the Time to Buy This Blue-Chip Healthcare Stock?Abbott Laboratories recently became a Dividend King.
Feb 19, 2022 by Kody Kester4 Reasons to Buy This Dividend Aristocrat NowMcDonald's stock is more than just its reputation as a Dividend Aristocrat.
Feb 19, 2022 by Kody KesterShould You Invest in Medical Properties Trust Right Now?Depending on your investment objectives, the healthcare real estate investment trust could be a buy.
Feb 19, 2022 by Kody KesterWorried About Inflation? This Dividend King Is a No-Brainer BuyJ&J's dividend growth only scratches the surface of why income investors should buy the stock.
Feb 18, 2022 by Kody KesterAbbVie Snags FDA Approval for Another Indication. Will It Become Another Blockbuster?Immunology drug Skyrizi was authorized by the Food and Drug Administration to treat psoriatic arthritis.
Feb 17, 2022 by Kody KesterIs This High-Yielding Dividend King a Buy?Altria Group's revenue net of excise taxes and earnings both edged higher in 2021. That modest growth should continue.
Feb 16, 2022 by Kody KesterAmgen Snags Another Approval for This Promising Cancer DrugJapan's regulatory agency recently authorized Lumakras as a treatment for a type of lung cancer.
Feb 15, 2022 by Kody Kester3 Top Biotech Stocks to Buy Right NowGlobal pharmaceutical spending is positioned to keep growing. These three companies can profit from the trend.
Feb 14, 2022 by Kody KesterGot $1,000? 5 Buffett Stocks to Buy and Hold ForeverThese Berkshire Hathaway stocks are trading at reasonable valuations for their quality.
Feb 12, 2022 by Kody Kester2 Top Healthcare Stocks to Buy Right NowMedtronic and AstraZeneca are trading at appealing valuations for the long run.
Feb 12, 2022 by Kody Kester2 Dividend Stocks That Will Pay You for LifeBoth of these stocks are Dividend Aristocrats with proven business models that enrich shareholders.
Feb 10, 2022 by Kody Kester4 of the Safest Dividend Stocks to Help You Crush InflationEach of these stocks enjoys competitive advantages in their respective industries.
Feb 8, 2022 by Kody KesterWhy It's Time To Buy This Blue-Chip Dividend Growth StockInvestors looking for a growing stream of income should consider buying UnitedHealth Group.
Feb 8, 2022 by Kody KesterIs This First-Class Dividend Stock a Buy?U.S. Bancorp ended 2021 with a difficult quarter, but things are still looking up.
Feb 7, 2022 by Kody KesterWhy This High-Quality Stock Is a Buy in 2022KeyCorp closed out 2021 with another strong quarter. But there are other reasons to buy the stock, too.
Feb 7, 2022 by Kody KesterAbbVie Wins Yet Another Approval for This DrugRinvoq was recently authorized in the U.S. as a treatment for patients with moderate-to-severe eczema.
Feb 5, 2022 by Kody KesterCould This New Indication Create a Blockbuster for Pfizer?Cibinqo was approved in the U.S. to treat patients with moderate to severe eczema.
Feb 4, 2022 by Kody Kester$300 a Month in These 3 REITs Could Make You a MillionaireThese three stocks have compounded at 12% to 17% annualized rates over the past 10 years.
Feb 3, 2022 by Kody KesterThis Blue Chip Stock Upped Its Dividend: Should You Buy It?The reasons to buy BlackRock's stock extend beyond just the recent dividend hike.
